ChartMill assigns a Buy % Consensus number of 83% to PBLA. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-06-24 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-05-16 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-04-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-27 | Roth MKM | Maintains | Buy -> Buy |
| 2024-02-05 | Roth MKM | Maintains | Buy -> Buy |
| 2023-12-18 | Roth MKM | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-02 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-26 | HC Wainwright & Co. | Initiate | Buy |
| 2023-03-20 | Maxim Group | Upgrade | Hold -> Buy |
| 2023-01-31 | Roth Capital | Reiterate | Buy |
| 2022-10-12 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-06-28 | Roth Capital | Initiate | Buy |
| 2021-03-10 | Maxim Group | Initiate | Buy |
8 analysts have analysed PBLA and the average price target is 418.2 USD. This implies a price increase of 37575.68% is expected in the next year compared to the current price of 1.11.
The consensus rating for PANBELA THERAPEUTICS INC (PBLA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering PANBELA THERAPEUTICS INC (PBLA) is 8.